GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bespoke Extracts Inc (OTCPK:BSPK) » Definitions » EV-to-EBITDA

Bespoke Extracts (Bespoke Extracts) EV-to-EBITDA : -1.16 (As of May. 13, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bespoke Extracts EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bespoke Extracts's enterprise value is $1.62 Mil. Bespoke Extracts's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.39 Mil. Therefore, Bespoke Extracts's EV-to-EBITDA for today is -1.16.

The historical rank and industry rank for Bespoke Extracts's EV-to-EBITDA or its related term are showing as below:

BSPK' s EV-to-EBITDA Range Over the Past 10 Years
Min: -13.2   Med: -1.26   Max: 3.26
Current: -1.16

During the past 13 years, the highest EV-to-EBITDA of Bespoke Extracts was 3.26. The lowest was -13.20. And the median was -1.26.

BSPK's EV-to-EBITDA is ranked worse than
100% of 708 companies
in the Drug Manufacturers industry
Industry Median: 14.76 vs BSPK: -1.16

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Bespoke Extracts's stock price is $0.05. Bespoke Extracts's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.150. Therefore, Bespoke Extracts's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bespoke Extracts EV-to-EBITDA Historical Data

The historical data trend for Bespoke Extracts's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bespoke Extracts EV-to-EBITDA Chart

Bespoke Extracts Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 -0.83 -3.85 -0.65 -1.05

Bespoke Extracts Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.65 -1.02 -0.96 -1.48 -1.05

Competitive Comparison of Bespoke Extracts's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bespoke Extracts's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bespoke Extracts's EV-to-EBITDA falls into.



Bespoke Extracts EV-to-EBITDA Calculation

Bespoke Extracts's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1.619/-1.393
=-1.16

Bespoke Extracts's current Enterprise Value is $1.62 Mil.
Bespoke Extracts's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bespoke Extracts  (OTCPK:BSPK) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bespoke Extracts's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.05/-0.150
=At Loss

Bespoke Extracts's share price for today is $0.05.
Bespoke Extracts's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.150.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bespoke Extracts EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bespoke Extracts's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bespoke Extracts (Bespoke Extracts) Business Description

Traded in Other Exchanges
N/A
Address
12001 E. 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.
Executives
Michael Feinsod director, 10 percent owner, officer: CEO
Tyler Hunter Garth director, officer: President 6300 E HAMPDEN AVE, 2306, DENVER CO 80222
Danil Pollack 10 percent owner, officer: President and CEO 6 GAUGUIN AVE., VAUGHAN A6 L4J9J7
Niquana Monique Noel 10 percent owner, officer: President and CEO 1316 SW 3RD COURT, FT. LAUDERDALE FL 33312
Marc Yahr director, 10 percent owner, officer: President and CEO 1966 NE 123RD STREET, NUM 170, NORTH MIAMI FL 33181
Anthony Ivankovich 10 percent owner 971 CRANDON BLVD., APT. PH-6, KEY BISCAYNE FL 33149
Mcglothlin Holdings, Ltd. 10 percent owner 402 W. DAVIS, LULING TX 78648
Barry Tenzer director, 10 percent owner, officer: President, CEO, CFO 290 LENOX AVENUE, NEW YORK NY 10027
Roberto Fata director, 10 percent owner, officer: Executive VP 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027
Lyle Hauser 10 percent owner 290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027